Your browser doesn't support javascript.
loading
HDAC1,2 inhibition and doxorubicin impair Mre11-dependent DNA repair and DISC to override BCR-ABL1-driven DSB repair in Philadelphia chromosome-positive B-cell precursor acute lymphoblastic leukemia.
Tharkar-Promod, S; Johnson, D P; Bennett, S E; Dennis, E M; Banowsky, B G; Jones, S S; Shearstone, J R; Quayle, S N; Min, C; Jarpe, M; Mosbruger, T; Pomicter, A D; Miles, R R; Chen, W Y; Bhalla, K N; Zweidler-McKay, P A; Shrieve, D C; Deininger, M W; Chandrasekharan, M B; Bhaskara, S.
Afiliación
  • Tharkar-Promod S; Department of Radiation Oncology, University of Utah School of Medicine, Salt Lake City, UT, USA.
  • Johnson DP; Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA.
  • Bennett SE; Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA.
  • Dennis EM; Department of Oncological Sciences, University of Utah School of Medicine, Salt Lake City, UT, USA.
  • Banowsky BG; Department of Radiation Oncology, University of Utah School of Medicine, Salt Lake City, UT, USA.
  • Jones SS; Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA.
  • Shearstone JR; Department of Radiation Oncology, University of Utah School of Medicine, Salt Lake City, UT, USA.
  • Quayle SN; Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA.
  • Min C; Department of Radiation Oncology, University of Utah School of Medicine, Salt Lake City, UT, USA.
  • Jarpe M; Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA.
  • Mosbruger T; Acetylon Pharmaceuticals Inc., Boston, MA, USA.
  • Pomicter AD; Regenacy Pharmaceuticals Inc., Boston, MA, USA.
  • Miles RR; Acetylon Pharmaceuticals Inc., Boston, MA, USA.
  • Chen WY; Acetylon Pharmaceuticals Inc., Boston, MA, USA.
  • Bhalla KN; Acetylon Pharmaceuticals Inc., Boston, MA, USA.
  • Zweidler-McKay PA; Regenacy Pharmaceuticals Inc., Boston, MA, USA.
  • Shrieve DC; Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA.
  • Deininger MW; Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA.
  • Chandrasekharan MB; Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT, USA.
  • Bhaskara S; Department of Cancer Biology, City of Hope National Medical Center, Duarte, CA, USA.
Leukemia ; 32(1): 49-60, 2018 01.
Article en En | MEDLINE | ID: mdl-28579617
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Cromosoma Filadelfia / Leucemia-Linfoma Linfoblástico de Células Precursoras B / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas de Fusión bcr-abl / Reparación del ADN / Histona Desacetilasa 1 / Histona Desacetilasa 2 Límite: Animals / Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Cromosoma Filadelfia / Leucemia-Linfoma Linfoblástico de Células Precursoras B / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas de Fusión bcr-abl / Reparación del ADN / Histona Desacetilasa 1 / Histona Desacetilasa 2 Límite: Animals / Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos